Analyst and Research & Development Day to be held in New York on November 10 at 8:30 am. Webcast Link
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VAXX:
- Vaxxinity to hold analyst and research and development day
- Vaxxinity to Present at Upcoming Investor Conferences in November
- Vaxxinity completes enrollment in Phase 3 trial of UB-612
- Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of Migraine
- Vaxxinity announces first subjects dosed in Phase 1 trial of UB-313